Organ-on-a-Chip Contract Research Services
Helping you understand and predict human response earlier
A better path to drug discovery and development
Species differences between animals and humans are a significant reason why ~90% of drug candidates fail in clinical trials. We think it’s time to do something about that. Emulate Organ-Chips predict human response better than conventional models, allowing higher quality drug candidates to advance to clinical trials. Let our team of experts de-risk your drug development pipeline with our wide variety of Organ-on-a-Chip compound testing services.
Application Spotlight: Predictive Toxicology
Organ-Chips predict drug toxicity in humans better than animals and other conventional models.
With our team of scientists dedicated to Organ-Chip contract research projects, there’s no easier way to unlock the predictive power of Organ-on-a-Chip technology. Schedule a call with one of our experts to see what we can help you discover.
Predictive Toxicology: Organ-Chips Demonstrate Superior Performance to Animal Models and Spheroids
Presented by Jack Scannell, PhD – Managing Director, Scannell Analytics LTD, Author of Eroom’s Law, Lorna Ewart, PhD – Chief Scientific Officer, Emulate, Daniel Levner, PhD – Co-Founder, Board Member, Emulate
De-risking Drug Development with Organ-on-a-Chip Contract Research Services
Presented by Sauveur Jeanty, Ph.D. – Principal Scientist, Emulate, Rebecca Bonfig, Ph.D. – Associate Director of Marketing, Emulate
Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology
Communications Medicine | December 2022
Therapeutic Antibody Pharmacology Applications on the Human Liver-Chip
Presented by Pelin Candarlioglu, PhD – Cell Biologist and Bioengineer, GlaxoSmithKline & Chair of Industry Advisory Board at EUROOcs
Modeling Inflammatory Immune Cell Recruitment and Response with the Colon Intestine-Chip
Presented by Chris Carman, PhD – Director of Immunology, Emulate